According to filings with the U.S. Securities and Exchange Commission, Huxley Medical, Inc. is raising up to $10,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Huxley Medical, Inc.
Huxley Medical, Inc. was founded by serial entrepreneurs to bring clinical-grade care to any person anywhere. We collaborate with thought-leading clinicians and researchers to simplify diagnoses and treatments with multifunction devices using machine-learned algorithms. We have recently developed SANSA, a wearable multi-sensor patch to diagnose multiple diseases simultaneously over several days. .

To learn more about Huxley Medical, Inc., visit https://www.huxleymed.com/
Huxley Medical, Inc. Linkedin Page: https://www.linkedin.com/company/huxley-medical-inc/

Contact:
Cristopher Lee, President and Chief Executive Officer
630-796-1772

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.